Tag: brainstorm cell therapeutics

September 21, 2020

10 Top Stem Cell Companies on the NASDAQ

The global stem cell therapy market is expected to grow at a CAGR of 36 percent between 2017 and 2021....
October 7, 2019

BrainStorm Receives US Patent Allowance for NurOwn Platform

The company received a notice of allowance for its US Patent Application called 'Method of Qualifying Cells.'
January 22, 2019

BrainStorm Granted Additional Patent for NurOwn in Israel

BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leader in developing innovative autologous cellular therapies for debilitating neurodegenerative diseases, today announced that the...
January 18, 2019

This is the Year for NurOwn’s Stem Cell Phase 3 ALS Development

Brainstorm Cell Therapeutics' management team discusses an ongoing ALS Phase 3 clinical trial, the company's technology and more.
January 7, 2019

Notes from the Floor: Biotech Showcase, Day 1

The Biotech Showcase takes place in San Francisco from January 7 to 9. Here's what went on during the conference...
December 17, 2018

FDA Accepts BrainStorm’s NurOwn IND Application for Progressive Multiple Sclerosis

BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, announced that the...
August 23, 2018

BrainStorm Cell Therapeutics Announces Positive Interim Safety Analysis

On Thursday, BrainStorm Cell Therapeutics announced that its Phase 3 trial for NurOwn in patients with ALS will be able...